Cancer Immunol. Res. 7, 1849–1863 (2019). Article PubMed Google Scholar Nissen, M. D., Sloan, E. K. & Mattarollo, S. R. β-Adrenergic signaling impairs antitumor CD8+ T-cell responses to B-cell lymphoma immunotherapy. Cancer Immunol. Res. 6, 98–109 (2018). Article CAS PubMed...
Cancer Immunol Res. 2020;8:1393–406. Article CAS PubMed Google Scholar Li A, Herbst RH, Canner D, Schenkel JM, Smith OC, Kim JY, et al. IL-33 signaling alters regulatory T cell diversity in support of tumor development. Cell Rep. 2019;29:2998–3008.e2998. Article CAS PubMed Pub...
resulting in a poor response of effector CD8+cytotoxic T cells against tumors [13]. To suppress protective immunity, cancer cells also produce IL-10 (interleukin-10) and different growth factors such as VEGF (vascular endothelial growth factor) and TGF (transforming growth factor) [14,15,16...
Cancer Immunol Res. 2021;9(12):1383–99. CAS PubMed Google Scholar Meng X, Zhao Y, Han B, Zha C, Zhang Y, Li Z, Wu P, Qi T, Jiang C, Liu Y, et al. Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling ...
2023;562:216182. Article CAS PubMed Google Scholar Woan KV, Miller JS. Harnessing natural killer cell Antitumor Immunity: from the Bench to Bedside. Cancer Immunol Res. 2019;7(11):1742–7. Article CAS PubMed PubMed Central Google Scholar Paczulla AM, Rothfelder K, Raffel S, Konantz...
Interleukin-2 (IL-2) and its receptor (IL-2R) are essential in orchestrating immune responses. Their function and expression in the tumor microenvironment make them attractive targets for immunotherapy, leading to the development of IL-2/IL-2R-targeted t
Immunol Rev. 2012;246(1):379–400. Google Scholar Liotti F, Visciano C, Melillo RM. Inflammation in thyroid oncogenesis. Am J Cancer Res. 2012;2(3):286–97. Google Scholar Maccio A, Madeddu C. Inflammation and ovarian cancer. Cytokine. 2012;58(2):133–47. CAS Google Scholar ...
Immunol Res. 2004;30:261–77. Article PubMed Google Scholar Bhardwaj M, Weigl K, Tikk K, Holland-Letz T, Schrotz-King P, Borchers CH, Brenner H. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer. Eur J Cancer. 2020;...
Front. Immunol. 4, 438 (2013). Article PubMed PubMed Central Google Scholar Ray-Coquard, I. et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 69, 5383–5391 (2009). Article CAS PubMed PubMed Central Google ...
Cancer Immunol. Res. 4, 936–947 (2016). Article CAS PubMed PubMed Central Google Scholar Zhi, J. et al. Inhibition of BRAF sensitizes thyroid carcinoma to immunotherapy by enhancing tsMHCII-mediated immune recognition. J. Clin. Endocrinol. Metab. 106, 91–107 (2021). Article PubMed ...